Transarterial Chemoembolization for Patients With Hepatocellular Carcinoma Using Miriplatin Without the Need for Hydration

Documenti analoghi

• Fibroblast growth factor receptor 2 alterations in intrahepatic cholangiocarcinoma: Prevalence and clinical implications in Asian populations
  di: Kyoko Oura, et al.
  Pubblicazione: (2025)
• Prognostic Value of a Novel Model for Hepatocellular Carcinoma Patients Undergoing Transarterial Chemoembolization
  di: Cailing Ye, et al.
  Pubblicazione: (2025)
• Application of Machine Learning for Predicting Progression‐Free and Overall Survival in Patients With Renal Cell Carcinoma
  di: Caroline W. Grant, et al.
  Pubblicazione: (2025)
• Do Patients With Alcoholic Cirrhosis Accurately Recognize Their Alcohol Tolerance? A Study Comparing Self‐Perception and ALDH2/ADH1B Genotype
  di: Tomoko Tadokoro, et al.
  Pubblicazione: (2025)
• Widespread Muscle Loss in Autoimmune Hepatitis and Its Adverse Prognostic Impact
  di: Tomoko Tadokoro, et al.
  Pubblicazione: (2026)